ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rao, P. S.
Right arrow Articles by Guinn, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rao, P. S.
Right arrow Articles by Guinn, G.

Ann Thorac Surg 1989;47:589-592
© 1989 The Society of Thoracic Surgeons

Articles

Anticoagulant therapy in children with prosthetic valves

P.Syamasundar Rao, MD*,a,b, Laszlo Solymar, MDa,b, Mohammed K. Mardini, MDa,b, Mohammed E. Fawzy, MDa,b, Gene Guinn, MDa,b

a Departments of Pediatrics, Medicine, and Surgery, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
b Department of Pediatrics, University of Wisconsin, School of Medicine, Madison, Wisconsin, USA

Accepted for publication October 26, 1988.

* Address reprint requests to Dr Rao, Department of Pediatrics, University of Wisconsin Hospital and Clinics, 600 Highland Ave, Madison, WI 53792.

The purpose of this study was to evaluate the effectiveness and complications of several types of anticoagulant therapy in children with prosthetic valves. During a 7-year period ending April 1985, 130 children aged 1 to 19 years underwent left-sided valve replacement. Operative mortality was 3%, 5%, and 9%, respectively, for aortic, mitral, and aortic and mitral valve replacement. Among the 123 survivors, 32 (26%) had had aortic, 71 (58%) had had mitral, and 20 (16%) had had aortic and mitral valve replacement. Follow-up ranged from 2 months to 8.2 years, a total of 544 patient-years. The survivors were divided into three groups based on anticoagulant treatment: warfarin sodium, aspirin plus dipyridamole, and no anticoagulants. Among the patients who had aortic valve replacement, thromboembolic complications developed in 2.5% ([equation] patient-years) of the aspirin plus dipyridamole group and 5% of the group given no anticoagulants. Only the warfarin group (4%) experienced bleeding complications. Among the patients having mitral valve replacement, thromboembolic complications developed in 4% of the warfarin group, 3% of the aspirin plus dipyridamole group, and 11% of the no anticoagulant group. In addition, 2% of patients in the warfarin group experienced severe bleeding. Two fatal cerebrovascular accidents occurred, both in the aspirin plus dipyridamole group. Patients who received a mitral heterograft were not prescribed any anticoagulant medications, and no thromboembolic complications developed. Among patients having doable-valve replacement, complications developed in 5% of the warfarin group and 27% of the group given no anticoagulants. Based on these data, aspirin plus dipyridamole appears adequate for patients having aortic valve replacement, whereas warfarin is required in patients having double-valve replacement. Patients having mitral valve replacement with heterografts require no anticoagulation, but those with mechanical valves may need warfarin anticoagulation. There are not adequate data to evaluate the safety and efficacy of the combined use of warfarin and a platelet-inhibiting drug in children.




This article has been cited by other articles:


Home page
 ChestHome page
P. Monagle, A. K. C. Chan, N. A. Goldenberg, R. N. Ichord, J. M. Journeycake, U. Nowak-Gottl, and S. K. Vesely
Antithrombotic Therapy in Neonates and Children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Chest, February 1, 2012; 141(2_suppl): e737S - e801S.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M.-S. Si and A. Zapolanski
A 37-Year-Old Smeloff-Cutter Aortic Valve
Ann. Thorac. Surg., February 1, 2009; 87(2): 628 - 629.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
P. Monagle, E. Chalmers, A. Chan, G. deVeber, F. Kirkham, P. Massicotte, and A. D. Michelson
Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest, June 1, 2008; 133(6_suppl): 887S - 968S.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. Masuda, H. Kado, H. Tatewaki, Y. Shiokawa, and H. Yasui
Late results after mitral valve replacement with bileaflet mechanical prosthesis in children: evaluation of prosthesis-patient mismatch
Ann. Thorac. Surg., March 1, 2004; 77(3): 913 - 917.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
P. Monagle, A. D. Michelson, E. Bovill, and M. Andrew
Antithrombotic Therapy in Children
Chest, January 1, 2001; 119(2009): 344S - 370S.
[Full Text] [PDF]

Home page
 Eur J Cardiothorac SurgHome page
T. Gunther, D. Mazzitelli, C. Schreiber, M. Wottke, S.-U. Paek, H. Meisner, and R. Lange
Mitral-valve replacement in children under 6 years of age
Eur J Cardiothorac Surg, April 1, 2000; 17(4): 426 - 430.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
W. Streif, M. Andrew, V. Marzinotto, P. Massicotte, A.K.C. Chan, J.A. Julian, and L. Mitchell
Analysis of Warfarin Therapy in Pediatric Patients: A Prospective Cohort Study of 319 Patients
Blood, November 1, 1999; 94(9): 3007 - 3014.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
L. A Durham III, S. E. desJardins, R. S. Mosca, and E. L. Bove
Ross Procedure With Aortic Root Tailoring for Aortic Valve Replacement in the Pediatric Population
Ann. Thorac. Surg., August 1, 1997; 64(2): 482 - 486.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
S. M. Bradley, R. M. Sade, F. A. Crawford Jr, and M. R. Stroud
Anticoagulation in Children With Mechanical Valve Prostheses
Ann. Thorac. Surg., July 1, 1997; 64(1): 30 - 34.
[Abstract] [Full Text]

Home page
 CirculationHome page
F. M. Lupinetti, J. Warner, T. K. Jones, and S. P. Herndon
Comparison of Human Tissues and Mechanical Prostheses for Aortic Valve Replacement in Children
Circulation, July 1, 1997; 96(1): 321 - 325.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
A. K. Cabalka, R. W. Emery, R. J. Petersen, H. K. Helseth, M. Jakkula, K. V. Arom, and D. M. Nicoloff
Long-term follow-up of the St. Jude medical prosthesis in pediatric patients
Ann. Thorac. Surg., December 1, 1995; 60(suppl_3): S618 - S623.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
B. Gometza and C. M. G. Duran
Ball valve (smeloff-cutter) aortic valve replacement without anticoagulation
Ann. Thorac. Surg., November 1, 1995; 60(5): 1312 - 1316.
[Abstract] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
H. Pouleur and M. Buyse
EFFECTS OF DIPYRIDAMOLE IN COMBINATION WITH ANTICOAGULANT THERAPY ON SURVIVAL AND THROMBOEMBOLIC EVENTS IN PATIENTS WITH PROSTHETIC HEART VALVESA meta-analysis of the randomized trials
J. Thorac. Cardiovasc. Surg., August 1, 1995; 110(2): 463 - 472.
[Abstract] [Full Text]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
M. Ibrahim, J. Cleland, H. O'Kane, D. Gladstone, C. Mullholland, and B. Craig
St. Jude Medical prosthesis in children
J. Thorac. Cardiovasc. Surg., July 1, 1994; 108(1): 52 - 56.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1989 by The Society of Thoracic Surgeons.